Angelini Pharma S.p.a.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Angelini Licenses Cureverse’s Nov

Angelini SPA has unveiled initial plans to grow its ThermaCare brand after closing its acquisition of the global rights, excluding North America, to the OTC pain-relief line from GSK Consumer Health

Moving into the dermocosmetics market helped Galenica’s Verfora Swiss consumer healthcare business achieve double-digit growth in 2019. Verfora’s sales advanced by 11.4% to CHF82.1m ($84.8m) in the 12

Sanofi has divested two OTC brands to Italy’s Angelini SPA in a deal worth €47m ($51m). The French firm signaled earlier this year that it would continue to rationalize its Consumer Healthcare port